![](/img/cover-not-exists.png)
Brentuximab Vedotin for Treating Relapsed or Refractory CD30-Positive Cutaneous T-Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Stainthorpe, Angela, Fleeman, Nigel, Houten, Rachel, Chaplin, Marty, Boland, Angela, Beale, Sophie, Dundar, Yenal, McEntee, Joanne, Syndikus, IsabelLanguage:
english
Journal:
PharmacoEconomics - Open
DOI:
10.1007/s41669-020-00203-0
Date:
March, 2020
File:
PDF, 1.07 MB
english, 2020